Nalaganje...
Efficacy and Safety of Guselkumab, an Anti–interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial
IMPORTANCE: Palmoplantar pustulosis (PPP) is a recalcitrant skin disease with no biologics currently approved for treatment. The involvement of interleukin 23 (IL-23) and cytokines of the type 17 helper T cell lineage in the pathogenesis of PPP has been recently postulated. OBJECTIVE: To evaluate th...
Shranjeno v:
| izdano v: | JAMA Dermatol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Medical Association
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885837/ https://ncbi.nlm.nih.gov/pubmed/29417135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.5937 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|